VIRVir Biotechnology, Inc.

$11.10

What is the market doing?

What the tape says about VIR

Vir Biotechnology, Inc. is +155% over the past year while the S&P 500 is +23%: 133 points ahead of the market.

+155%

1-year return · S&P 500 +23%

vs 200-day average
+36%

vs 200-day average · a clear uptrend

RSI (14)
84

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
0.00%

Below its 52-week high

2024-08-06$4.28 – $12.48 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$11.10
1 monthS&P 500 +3.7%
+19%
1 yearS&P 500 +23%
+155%
5 yearsS&P 500 +87%
−69%
vs 50-day average$9.24
+20%
52-week high
$11.10
52-week low
$4.28
Annualised volatility
78%
Calendar-year price return
YearReturn
2026 (year to date)+84%
2025−18%
2024−27%
2023−60%
2022−40%
2021+56%
2020+113%
Average return by calendar month, 2019–2026
MonthYearsPositiveAverage
Jan75 of 7+44%
Feb73 of 7+6.4%
Mar72 of 7−11%
Apr72 of 7−5.5%
May74 of 7+4.0%
Jun74 of 7+2.2%
Jul74 of 7−5.3%
Aug72 of 7+1.3%
Sep61 of 6−12%
Oct62 of 6−3.1%
Nov76 of 7+11%
Dec72 of 7−5.8%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.